Thursday, June 08, 2023 2:38:42 PM
The SEC can have a note cancelled, which only means the conversion of note to common stock will not occur, but the debt will not go away. In really really simple terms Endonovo is going to have to pay back the money with the negotiated interest accrued in full.
Putting that aside, in the last SEC filing the fully diluted stock count went to 1.7 Billion for the quarter ended March 2023, compared to 79 Million for the quarted ended March 2022.
That 1.7 Billion has nothing to do with the current $26 million in debt the company still owes.
That is massive dilution and there will be further dilution moving forward.
Putting aside the legal issues with Auctus, forgetting about the outrageous dilution that has already occurred, Endonovo reported $87 thousand in revenues for the quarter ended March 2023.
That is embarrassing for a company that has made so many claims about great product, revenue projections, partnerships, etc,
I also think the past is indicative of the future.
I think when CEO's issue press releases with forecasts including proforma numbers and deal-terms and new company formations and uplisting to nasdaq, none of which comes true, it shows a pattern of the CEO basically lying, and that reflects on his character and believeabilty.
I also feel that when a CEO of a public company has never attracted a single institutional investor over a 20 year period, it means there is no business, no trust in the CEO and that means the stock will never increase because as well know, institutional ownership is a necessity for sustainable market cap appreciation.
I also know that the lack of liquidity in the market right now in ENDV stock means there is no belief in the company. Not even retail investors are buying the stock. The company has made a number of press releases this year alone, meanwhile no one is buying the stock. What does that tell you, if you are a common-sense person.
The lack of new investors illustrates the probability of stock ever going up.
Recent ENDV News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM